The Prospect of a National Lab ServiceWill Creating Standard Methods and Samples Speed Approval of New Markers?By Deborah Levenson
The concept of a national diagnostic testing service raises some serious questions. Known as the United States Diagnostic Standards, the lab would design testing protocols and provide standardized clinical sample procurement, data processing, and readouts.
After Long Wait, GINA Becomes LawWill Labs See an Increase in Demand For Genetic Testing?By Phil Kibak
Recently signed into law, the Genetic Information Nondiscrimination Act (GINA) prohibits employers and health insurers from discrimination based on a person’s genetic information. Medical researchers believe the law will lead to an increase in screening and testing for recognized genetic diseases, as well as boost participation in clinical research studies.
Lipid BiomarkersIdentifying Dyslipidemia in ChildrenBy Katherine Morrison, MD, FRCPC, and Vijaylaxmi Grey, PhD, FCACB
While dyslipidemia seldom results in adverse clinical outcomes during childhood, epidemiological studies demonstrate that cholesterol levels in children track into adulthood. Therefore, identifying children who are at risk by assessing lipids and lipoproteins is an important health strategy.
IVD Market Growth Looks Favorable
Introducing CLN’s New Special Section Nancy Sasavage, PhD
Current Concepts in the Disclosure of Serious Medical Errors to PatientsAn Interview with Thomas Gallagher, MD
Quality Gaps in Communicating Laboratory ResultsAn Interview with Dana Grzybicki, MD
Communication: Teaching Cases on the WebAHRQ’s Web Morbidity and Mortality Rounds
News From the FDA
Download the entire issue
Lab Quality: A Status Report
Painless Testing: Upcoming Saliva Tests